Although intratumoral injection of in vivo siRNA either enhanced or slightly interfered with the antitumorigenic effect of IR, PRMT5-ISO5 still improved the efficiency of radiotherapy in HCC cells. Here, PRMT5 is linked to hepatocellular carcinoma.